Tennr

AI that reads faxed referrals and moves them to booked visits

Our take

Tennr automates the paperwork that moves patients between providers. Its specialized vision-language models (RaeLM, trained on 100 million healthcare documents) read incoming faxes and referral packets, extract the clinical and demographic data, verify eligibility and benefits, check the documentation against payer criteria, and push clean orders into systems like Brightree and NikoHealth. Core customers are HME/DME suppliers, imaging centers, labs, infusion and specialty pharmacy, and sleep businesses, with named users including Rothman Orthopaedics, Talkiatry, and TwelveStone Health Partners.

Founded in 2021 in New York, Tennr has raised over $160M, most recently a $101M Series C led by IVP in June 2025 at a $605M valuation, with Andreessen Horowitz, Lightspeed, ICONIQ, and GV participating. The company says it processes 10 million documents a month and tripled revenue in the quarters after its Series B. Its 2025 Tennr Network launch adds referral status visibility for senders and patients. For referral-heavy operators the ROI case is direct: fewer manual touches per order and fewer denials from missing documentation.

What it does

Reads faxed referrals and extracts structured patient data
Proprietary RaeLM models trained on 100M healthcare documents
Qualifies patients against payer documentation criteria automatically
Runs eligibility and benefits checks on incoming referrals
Routes orders and populates downstream intake systems
Tennr Network gives referrers and patients live referral status

Where it's strong

Best-in-class at the ugly problem of fax and document-based referral intake, processing 10 million documents a month.
Purpose-built models check documentation against payer criteria upfront, which cuts denials rather than just speeding data entry.
Heavy funding ($101M Series C at a $605M valuation) and tripling revenue suggest it will keep shipping fast.

What buyers should weigh

Strongest in referral-driven businesses like HME/DME, imaging, labs, and infusion; less relevant if referrals are not your bottleneck.
Still a young company scaling quickly, so implementation attention may vary as the customer base grows.
Pricing is volume-based on document throughput, which buyers should model carefully against current intake costs.
Plan for a 2-3 month implementation and roughly a year to full ROI.

Latest

Raised a $101M Series C led by IVP in June 2025 at a $605M valuation and launched Tennr Network for real-time referral visibility.